Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Prime Medicine (PRME) Other Operating Expenses (2023)

Prime Medicine filings provide 1 years of Other Operating Expenses readings, the most recent being $13.5 million for Q4 2023.

  • On a quarterly basis, Other Operating Expenses changed N/A to $13.5 million in Q4 2023 year-over-year; TTM through Sep 2024 was $13.5 million, a N/A change, with the full-year FY2023 number at $13.5 million, changed N/A from a year prior.
  • Other Operating Expenses hit $13.5 million in Q4 2023 for Prime Medicine.
  • In the past five years, Other Operating Expenses ranged from a high of $13.5 million in Q4 2023 to a low of $13.5 million in Q4 2023.